Intrexon | Creditori Commerciali





Creditori Commerciali Cambiamento Data
Agenus USD 85.29M 10.89M 2025-09
Alaunos Therapeutics USD 843K 34K 2025-09
Amgen USD 20.89B 1.25B 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Heron Therapeutics USD 12.02M 20K 2025-09
Incyte USD 1.63B 1.46B 2025-12
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
MannKind USD 7.27M 2.99M 2025-09
Merck USD 4.15B 102M 2025-09
Novartis USD 4.56B 49M 2025-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.12B 140M 2025-09
Veracyte USD 5.51M 5.94M 2025-09
Xencor USD 9.08M 9.45M 2025-09


Intrexon Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.